In the world’s most hyper-competitive aesthetic market of Beverly Hills, ‘good’ is a commodity and ‘new’ is everywhere. To truly disrupt this landscape, you need more than a luxury address; you need a mix of high-level clinical science and a real business backbone.
This is the story of Curiva Med Spa, and how founders Tamara Yang, DNP, and Amar Hirani, MBA, turned the XERF platform into a $100,000 revenue engine in just 35 days.
The Power of Two: The Clinical Architect and The Business Strategist
A winning formula is difficult to uncover, given both the rapid advancement of technology and the rising expectations of patients. Med Spa owners must master the engine of business operations while simultaneously perfecting the art of the treatment.
Curiva Med Spa solved this by splitting the DNA of the brand:
- The Clinical Architect: Co-founder Tamara Yang, a Johns Hopkins DNP, built Curiva Med Spa out of a personal obsession with skin health and wellness. Ivy League-educated with evidence-based clinical decision making, she doesn’t just add services to a menu because they are trendy, but hand-picks technology that are proven to work. For her, a new device isn’t just another service to add to a menu; it’s a clinical investment that has to prove its worth through hard data, statistical significance, and real results.
- The Business Strategist: Co-founder Amar Hirani, MBA, is the designer of Curiva Med Spa’s strategic edge. Drawing from a Fortune 10 playbook, he recognized that a business only succeeds when it stops trying to do everything and starts owning a category. Amar didn’t just launch the brand but he also engineered the sophisticated infrastructure that allows it to function. By building the invisible engine behind the scenes, he stripped away the administrative friction and streamlined processes. Without his systems, the focus on the patient would be lost; because of them, the clinical team is liberated to perform at their highest level.
The “K-Beauty” Strategy
Tamara recognized a significant gap in the aesthetic market. It was a gap that her current collection of world-class devices didn’t address. The missing piece was non-invasive structural skin tightening, so she rigorously evaluated all the leading devices. In August, she discovered the solution in South Korea, the birthplace of K-Beauty and a global leader in plastic surgery, with XERF by Cynosure Lutronic. Her mission: to bring best-in-class Korean innovation back to Beverly Hills for her patients.
The choice was a fusion of Tamara and Amar’s dual perspectives. For Tamara, XERF met her non-negotiable standard for scientific efficacy coupled with superior safety. For Amar, the technology’s prestige and results allowed them to build a category-of-one business model. By funneling their entire marketing weight and operational focus behind this single technology, they achieved immediate market saturation.
Rapid ROI: $100K Net in Just 5 Weeks
By combining Tamara’s customized, science-driven protocols with Amar’s platform designed for superior patient quality experience, the results were instantaneous:
- $100,000+ net revenue generated in the first five weeks.
- 45+ high-priority patients acquired through sophisticated patient outreach programs, digital funnels and elite partnerships with luxury gyms and real estate groups.
- A patient-focused team who executed the vision led by Maryam Kazemi, Stacey Mcgee and Samantha Garcia.
The Art of Compounding Treatments
Inspired by the advanced combination-therapy philosophies perfected in South Korea, Curiva Med Spa elevates XERF with a thoughtfully designed two-treatment protocol, complemented by additional therapies and follow-up services to enhance and extend results. This philosophy delivers outcomes far beyond a standard approach.
This strategy increases revenue and strengthens long-term patient loyalty, the marker of a thriving practice.
A Partnership Built for Scale
Tamara and Amar credit their rapid growth to a strong strategic partnership with Cynosure Lutronic and to the Curiva Med Spa team, who helped drive the initial wave of patient outreach by thoughtfully introducing XERF to existing patients—one person at a time.
From hands-on clinical demo days to responsive marketing guidance, the relationship allowed them to move from soft launch to a market leader at an accelerated pace.
The Verdict
In just five weeks, Tamara and Amar demonstrated what happens when a clinical architect works side by side with a business strategist, supported by a truly patient-first team. Their practice stands as proof of what happens when business decisions follow a clear product positioning strategy. Rooted in the uncompromising standards of Korean aesthetic excellence and powered by Cynosure Lutronic’s Korean technology, the results outperform business as usual.
Intended for distribution in the United States and Canada only.
The XERF device is intended for use in dermatologic and general surgical procedures for electrocoagulation and hemostasis. All instances of the term “skin tightening” are used to describe tightening effects that occur via soft tissue coagulation. Cynosure, LLC and Lutronic Aesthetic, Inc. do not diagnose or treat medical conditions, prescribe treatment protocols, provide medical advice, or otherwise practice medicine. Patients should consult with a qualified healthcare professional for diagnosis and proper treatment protocols/parameters to determine if treatment with any product is right for them. Qualified healthcare professionals are responsible for diagnosis and treatment protocols using products. ©2025 CYNOSURE LUTRONIC, INC. All Rights Reserved. Lutronic is a registered trademark and XERF is a trademark of Lutronic Corporation. Cynosure is a registered trademark of Cynosure, LLC.
Revenue and profitability outcomes for med spas vary based on numerous factors, including but not limited to practice size, patient mix, pricing, utilization, staffing, and market conditions. Any revenue or financial information presented is for illustrative purposes only and should not be considered a guarantee or projection of actual results.